Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concomitant sIPV and Hepatitis A Vaccines in Children
NCT06460545Phase 4Not yet recruiting
- Sponsor
- Institute of Medical Biology
- Start
- Jun 2024
- Primary completion
- Aug 2026
- Modality
- Live Biotherapeutic Products, Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of Sabin Inactivated Poliovirus Vaccine (Vero Cell), hepatitis A vaccine (live, attenuated), hepatitis A vaccine inactivated in poliomyelitis, hepatitis A (HAV), sponsored by Institute of Medical Biology. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
Sabin Inactivated Poliovirus Vaccine (Vero Cell)hepatitis A vaccine (live, attenuated)hepatitis A vaccine inactivated
03
Conditions
poliomyelitishepatitis A (HAV)
Beyond the preview
Go deeper on NCT06460545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06460545.